ClinConnect ClinConnect Logo
Search / Trial NCT04299984

Italian Multicenter Database for Open Conversions After EVAR

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA · Mar 5, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Abdominal Aortic Aneurysm Open Surgical Conversion Endovascular Repair Evar Explantation Failed Evar

ClinConnect Summary

This clinical trial is focused on understanding the best ways to treat complications that can happen after a procedure called endovascular abdominal aneurysm repair (EVAR). When patients have problems due to EVAR that can't be fixed by other endovascular methods, doctors have two main options: a late open conversion (LOC) or a semi-conversion (SC). LOC involves removing part or all of the original graft used in the repair, while SC means performing surgery to fix a specific issue without removing the graft. The goal of this study is to gather information on these two types of surgeries from multiple centers and to see how well they work in both the short and long term.

If you or a family member are between the ages of 65 and 74 and have had complications from EVAR that require open or laparoscopic surgery, you may be eligible to participate in this trial. However, if you have undergone other types of procedures not directly related to the graft, such as certain bypass surgeries, you would not qualify. Participants can expect to contribute to valuable research that may help improve future treatments for similar complications. The study is not yet recruiting, but it aims to provide important insights into the outcomes of different surgical approaches for EVAR complications.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • open or laparoscopic surgery for EVAR complications, with or without endograft explantation
  • Exclusion Criteria:
  • endovascular reinterventions
  • extra-anatomical bypass surgery (e.g. femoro-femoral crossover bypass) not associated with direct aorta/endograft surgery

About Azienda Ospedaliero Universitaria Di Parma

Azienda Ospedaliero-Universitaria di Parma is a leading hospital and university institution in Italy, dedicated to advancing medical research and patient care through innovative clinical trials. With a strong emphasis on collaboration between healthcare professionals and academic researchers, the organization aims to enhance therapeutic interventions and improve health outcomes across various medical fields. Its commitment to excellence in clinical research is reflected in its state-of-the-art facilities, multidisciplinary approach, and adherence to rigorous ethical standards, positioning it as a pivotal contributor to the advancement of medical science.

Locations

Parma, , Italy

Patients applied

0 patients applied

Trial Officials

Paolo Perini, MD

Principal Investigator

Parma University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials